How many possible fragments can be presented
Neolactosylceramide and isoglobosylceramide are two examples of oligoglycosylceramides associated with different pathologies of the central nervous system. Considering their structure, how many possible fragments can be presented via MHC class I and/or II from these specific examples and in general for all oligoglycosyceramides? Explain your answer.